University of California, San Francisco

3 articles about University of California, San Francisco

• 

  Psychedelics Poised for the Therapeutic Mainstream

  10/30/2023

  With the potential FDA approval of an MDMA-based therapy for PTSD on the horizon, biopharma stakeholders are eyeing psychedelics with fresh anticipation.

• Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies

  3/27/2023

  Thermo Fisher Scientific Inc. and the University of California, San Francisco, will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.

• University of California awarded CRISPR-Cas9-related patent for techniques that regulate gene expression

  5/28/2019

  USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription